Epigenetic mechanisms and kidney diseases

Current Medicinal Chemistry

Volumn 18, Issue 12, 2011, Pages 1733-1739

  Liakopoulos, V ^a   Georgianos, P I ^a   Eleftheriadis, T ^b   Sarafidis, P A ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

Chronic kidney disease; Diabetic nephropathy; Epigenetics; Kidney organogenesis; Transplantation

Indexed keywords

ANCA ASSOCIATED VASCULITIS; ARTICLE; BLOOD VESSEL CALCIFICATION; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; ENVIRONMENTAL EXPOSURE; EPIGENETICS; FETUS DEVELOPMENT; FIBROGENESIS; GENE EXPRESSION; GENETIC PREDISPOSITION; GLYCEMIC CONTROL; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERPHOSPHATEMIA; HYPERTENSION; INFLAMMATION; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY INJURY; NEPHRON; NONHUMAN; NUTRITION; OXIDATIVE STRESS; PATHOGENESIS; RNA INTERFERENCE; UREMIA;

DRUG DELIVERY SYSTEMS; EPIGENESIS, GENETIC; HUMANS; KIDNEY DISEASES;

EID: 79955676421     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711795496827     Document Type: Article

References (80)

1. Reik, W.; Dean, W.; Walter, J. Epigenetic reprogramming in mammalian development. Science., 2001, 293, 1089-1093. (Pubitemid 32758081)
2. Li, E.; Beard, C.; Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature., 1993, 366, 362-365. (Pubitemid 23349366)
3. Mohandas, T.; Sparkes, R.S.; Shapiro, L.J. Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science., 1981, 211, 393-396. (Pubitemid 11128749)
4. Bird, A.P. Functions for DNA methylation in vertebrates. Cold. Spring. Harb. Symp. Quant. Biol., 1993, 58, 281-285. (Pubitemid 24219488)
5. Berger, S.L. The complex language of chromatin regulation during transcription. Nature., 2007, 447, 407-412. (Pubitemid 46816746)
6. Li, B.; Carey, M.; Workman, J.L. The role of chromatin during transcription. Cell., 2007, 128, 707-719. (Pubitemid 46273570)
7. Takai, D.; Jones, P.A. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. USA., 2002, 99, 3740-3745. (Pubitemid 34252176)
8. Jeltsch, A. On the enzymatic properties of Dnmt1: specificity, processivity, mechanism of linear diffusion and allosteric regulation of the enzyme. Epigenetics., 2006, 1, 63-66.
9. Chen, T.; Li, E. Establishment and maintenance of DNA methylation patterns in mammals. Curr. Top. Microbiol. Immunol., 2006, 301, 179-201. (Pubitemid 43022672)
10. Mortusewicz, O.; Schermelleh, L.; Walter, J.; Cardoso, M.C.; Leonhardt, H. Recruitment of DNA methyltransferase I to DNA repair sites. Proc. Natl. Acad. Sci. USA., 2005, 102, 8905-8909. (Pubitemid 40881051)
11. Okano, M.; Bell, D.W.; Haber, D.A.; Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell., 1999, 99, 247-257. (Pubitemid 29519904)
12. Prendergast, G.C.; Lawe, D.; Ziff, E.B. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell., 1991, 65, 395-407. (Pubitemid 121002049)
13. Kass, S.U.; Landsberger, N.; Wolffe, A.P. DNA methylation directs a timedependent repression of transcription initiation. Curr. Biol., 1997, 7, 157-165. (Pubitemid 27164721)
14. Nan, X.; Campoy, F.J.; Bird, A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell., 1997, 88, 471-481. (Pubitemid 27154412)
15. Jones, P.L.; Veenstra, G.J.; Wade, P.A.; Vermaak, D.; Kass, S.U.; Landsberger, N.; Strouboulis, J.; Wolffe, A.P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet., 1998, 19, 187-191. (Pubitemid 28248804)
16. Jones, P.A.; Baylin, S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 2002, 3, 415-428. (Pubitemid 34587077)
17. Kouzarides, T. Chromatin modifications and their function. Cell., 2007, 128, 693-705. (Pubitemid 46273577)
18. Ohm, J.E.; Baylin, S.B. Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation? Cell. Cycle., 2007, 6, 1040-1043. (Pubitemid 46708576)
19. Tsukada, Y.; Fang, J.; Erdjument-Bromage, H.; Warren, M.E.; Borchers, C.H.; Tempst, P.; Zhang, Y. Histone demethylation by a family of JmjC domain- containing proteins. Nature., 2006, 439, 811-816. (Pubitemid 43255695)
20. Kangaspeska, S.; Stride, B.; Metivier, R.; Polycarpou-Schwarz, M.; Ibberson, D.; Carmouche, R.P.; Benes, V.; Gannon, F.; Reid, G. Transient cyclical methylation of promoter DNA. Nature., 2008, 452, 112-115. (Pubitemid 351355094)
21. Metivier, R.; Gallais, R.; Tiffoche, C.; Le Peron, C.; Jurkowska, R.Z.; Carmouche, R.P.; Ibberson, D.; Barath, P.; Demay, F.; Reid, G.; Benes, V.; Jeltsch, A.; Gannon, F.; Salbert, G. Cyclical DNA methylation of a transcriptionally active promoter. Nature., 2008, 452, 45-50. (Pubitemid 351355084)
22. Barker, D.J.; Bagby, S.P.; Hanson, M.A. Mechanisms of disease: in utero programming in the pathogenesis of hypertension. Nat. Clin. Pract. Nephrol., 2006, 2, 700-707. (Pubitemid 44862707)
23. Zandi-Nejad, K.; Luyckx, V.A.; Brenner, B.M. Adult hypertension and kidney disease: the role of fetal programming. Hypertension., 2006, 47, 502-508. (Pubitemid 43843866)
24. Duncan, R.C.; Bass, P.S.; Garrett, P.J.; Dathan, J.R. Weight at birth and other factors influencing progression of idiopathic membranous nephropathy. Nephrol. Dial. Transplant., 1994, 9, 875. (Pubitemid 24209777)
25. Nelson, R.G.; Morgenstern, H.; Bennett, P.H. Birth weight and renal disease in Pima Indians with type 2 diabetes mellitus. Am. J. Epidemiol., 1998, 148, 650-656. (Pubitemid 28498432)
26. Painter, R.C.; Roseboom, T.J.; van Montfrans, G.A.; Bossuyt, P.M.; Krediet, R.T.; Osmond, C.; Barker, D.J.; Bleker, O.P. Microalbuminuria in adults after prenatal exposure to the Dutch famine. J. Am. Soc. Nephrol., 2005, 16, 189-194. (Pubitemid 43073172)
27. Zidar, N.; Cavic, M.A.; Kenda, R.B.; Koselj, M.; Ferluga, D. Effect of intrauterine growth retardation on the clinical course and prognosis of IgA glomerulonephritis in children. Nephron., 1998, 79, 28-32. (Pubitemid 28204034)
28. Sinclair, K.D.; Allegrucci, C.; Singh, R.; Gardner, D.S.; Sebastian, S.; Bispham, J.; Thurston, A.; Huntley, J.F.; Rees, W.D.; Maloney, C.A.; Lea, R.G.; Craigon, J.; McEvoy, T.G.; Young, L.E. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc. Natl. Acad. Sci. USA., 2007, 104, 19351-19356.
29. Bogdarina, I.; Welham, S.; King, P.J.; Burns, S.P.; Clark, A.J. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ. Res., 2007, 100, 520-526. (Pubitemid 46673261)
30. Lillycrop, K.A.; Phillips, E.S.; Jackson, A.A.; Hanson, M.A.; Burdge, G.C. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J. Nutr., 2005, 135, 1382-1386. (Pubitemid 40799599)
31. Lillycrop, K.A.; Slater-Jefferies, J.L; Hanson, M.A.; Godfrey, K.M.; Jackson, A.A.; Burdge, G.C. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br. J. Nutr., 2007, 97, 1064-1073. (Pubitemid 46925358)
32. Lillycrop, K.A.; Phillips, E.S.; Torrens, C.; Hanson, M.A.; Jackson, A.A.; Burdge, G.C. Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPAR alpha promoter of the offspring. Br. J. Nutr., 2008, 100, 278-282.
33. Burdge, G.C.; Lillycrop, K.A.; Phillips, E.S.; Slater-Jefferies, J.L.; Jackson, A.A.; Hanson, M.A. Folic acid supplementation during the juvenile-pubertal period in rats modifies the phenotype and epigenotype induced by prenatal nutrition. J. Nutr., 2009, 139, 1054-1060.
34. Welham, S.J.; Riley, P.R.; Wade, A.; Hubank, M; Woolf, A.S. Maternal diet programs embryonic kidney gene expression. Physiol. Genomics., 2005, 22, 48-56. (Pubitemid 41356337)
35. Welham, S.J.; Wade, A; Woolf, A.S. Protein restriction in pregnancy is associated with increased apoptosis of mesenchymal cells at the start of rat metanephrogenesis. Kidney. Int., 2002, 61, 1231-1242. (Pubitemid 34304483)
36. Pham, T.D.; MacLennan, N.K.; Chiu, C.T.; Laksana, G.S.; Hsu, J.L.; Lane, R.H. Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2003, 285, R962-R970. (Pubitemid 37296346)
37. Wintour, E.M.; Moritz, K.M.; Johnson, K.; Ricardo, S.; Samuel, C.S.; Dodic, M. Reduced nephron number in adult sheep, hypertensive as a result of prenatal glucocorticoid treatment. J. Physiol., 2003, 549, 929-935. (Pubitemid 36889780)
38. Bertram, C.; Trowern, A.R.; Copin, N.; Jackson, A.A.; Whorwood, C.B. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology., 2001, 142, 2841-2853. (Pubitemid 32575519)
39. Baserga, M.; Hale, M.A.; Wang, Z.M.; Yu, X; Callaway, C.W.; McKnight, R.A.; Lane, R.H. Uteroplacental insufficiency alters nephrogenesis and downregulates cyclooxygenase-2 expression in a model of IUGR with adultonset hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2007, 292, R1943-R1955. (Pubitemid 46708550)
40. Baserga, M.; Kaur, R.; Hale, M.A.; Bares, A; Yu, X; Callaway, C.W.; McKnight, R.A.; Lane, R.H. Fetal growth restriction alters transcription factor binding and epigenetic mechanisms of renal 11beta-hydroxysteroid dehydrogenase type 2 in a sex-specific manner. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2010, 299, R334-R342.
41. Tonna, S.; El-Osta, A.; Cooper, M.E.; Tikellis, C. Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms. Nat. Rev. Nephrol., 2010, 6, 332-341
42. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Group. N. Engl. J. Med., 1993, 329, 977-986.
43. Ceriello, A. Hypothesis: the "metabolic memory", the new challenge of diabetes. Diabetes. Res. Clin. Pract., 2009, 86(Suppl 1), S2-S6.
44. Holman, R.R.; Paul, S.K.; Bethel, M.A.; Matthews, D.R.; Neil, H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med., 2008, 359(15), 1577-1589.
45. Engerman, R.L.; Kern, T.S. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes., 1987, 36(7), 808-812. (Pubitemid 17145301)
46. El-Osta, A.; Brasacchio, D.; Yao, D.; Pocai, A.; Jones, P.L.; Roeder, R.G.; Cooper, M.E.; Brownlee, M. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med., 2008, 205, 2409-2417.
47. Brasacchio, D.; Okabe, J.; Tikellis, C.; Balcerczyk, A.; George, P.; Baker, E.K.; Calkin, A.C.; Brownlee, M.; Cooper, M.E.; El-Osta, A. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes., 2009, 58, 1229-1236.
48. Siebel, A.L.; Fernandez, A.Z.; El-Osta, A. Glycemic memory associated epigenetic changes. Biochem. Pharmacol., 2010, 80, 1853-1859.
49. Villeneuve, L.M.; Reddy, M.A.; Lanting, L.L.; Wang, M.; Meng, L.; Natarajan, R. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc. Natl. Acad. Sci. USA., 2008, 105, 9047-9052.
50. Brennan, E.P.; Ehrich, M.; Brazil, D.P.; Crean, J.K.; Murphy, M.; Sadlier, D.M.; Martin, F.; Godson, C.; van den Boom, D.; Maxwell, A.P.; Savage, D.A. DNA methylation profiling in cell models of diabetic nephropathy. Epigenetics., 2010, 5, epub ahead of print.
51. Sayyed, S.G.; Gaikwad, A.B.; Lichtnekert, J.; Kulkarni, O.; Eulberg, D.; Klussmann, S.; Tikoo, K.; Anders, H.J. Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. Nephrol. Dial. Transplant., 2010, 25, 1811-1817.
52. Brancaccio, D.; Bellasi, A.; Cozzolino, M.; Galassi, A.; Gallieni, M. Arterial accelerated aging in dialysis patients: the clinical impact of vascular calcification. Curr. Vasc. Pharmacol., 2009, 7, 374-380.
53. Eddington, H.; Sinha, S.; Kalra, P.A. Vascular calcification in chronic kidney disease: a clinical review. J. Ren. Care., 2009, 35(Suppl 1), 45-50.
54. Shroff, R.C.; Shanahan, C.M. The vascular biology of calcification. Semin. Dial., 2007, 20, 103-109.
55. de Oca, M.A.; Madueno, J.; Martinez, J.; Guerrero, F.; Munoz-Castaneda, J.; Rodriguez, M.; Mendoza, F.; Almaden, Y.; Lopez, I.; Rodriguez, M.; Aguilera- Tejero, E. High phosphate-induced calcification is related to SM22alpha promoter methylation in vascular smooth muscle cells. J. Bone. Miner. Res., 2010, 25, 1996-2005.
56. Zeisberg, M.; Strutz, F.; Muller, G.A. Role of fibroblast activation in inducing interstitial fibrosis. J. Nephrol., 2000, 13(Suppl 3), S111-S120.
57. Neilson, E.G. Mechanisms of disease: Fibroblasts--a new look at an old problem. Nat. Clin. Pract. Nephrol., 2006, 2, 101-108. (Pubitemid 43355218)
58. Bechtel, W.; McGoohan, S.; Zeisberg, E.M.; Muller, G.A.; Kalbacher, H.; Salant, D.J.; Müller, C.A.; Kalluri, R.; Zeisberg, M. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat. Med., 2010, 16, 544-550.
59. Kloosterman W, Plasterk R. The diverse functions of microRNAs in animal development and disease. Dev Cell, 2006, 11(4), 441-450. (Pubitemid 44430905)
60. Bartel D, Chen C. Micromanagers of gene expression: The potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet., 2004, 5(3), 396-400. (Pubitemid 38529411)
61. Harvey SJ, Jarad G, Cunningham J, Goldberg S, Schermer B, Harfe BD, McManus MT, Benzing T, Miner JH. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. J. Am. Soc. Nephrol., 2008, 19(11), 2150-2158.
62. Shi S, Yu L, Chiu C, Sun Y, Chen J, Khitrov G, Merkenschlager M, Holzman LB, Zhang W, Mundel P, Bottinger EP. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J. Am. Soc. Nephrol., 2008, 19(11), 2159-2169.
63. Ekstrom, T.J.; Stenvinkel, P. The epigenetic conductor: a genomic orchestrator in chronic kidney disease complications? J Nephrol., 2009, 22, 442-449.
64. Perna, A.F.; Ingrosso, D.; Violetti, E.; Luciano, M.G.; Sepe, I.; Lanza, D.; Capasso, R.; Ascione, E.; Raiola, I.; Lombardi, C.; Stenvinkel, P.; Massy, Z.; De Santo, N.G. Hyperhomocysteinemia in uremia--a red flag in a disrupted circuit. Semin. Dial., 2009, 22, 351-356.
65. Bostom, A.G.; Shemin, D.; Verhoef, P.; Nadeau, M.R.; Jacques, P.F.; Selhub, J.; Dworkin, L.; Rosenberg, I.H. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler. Thromb. Vasc. Biol., 1997, 17, 2554-2558. (Pubitemid 28015993)
66. Ducloux, D.; Klein, A.; Kazory, A.; Devillard, N.; Chalopin, J.M. Impact of malnutrition-inflammation on the association between homocysteine and mortality. Kidney. Int., 2006, 69, 331-335. (Pubitemid 43323084)
67. Jamaluddin, M.S.; Yang, X.; Wang, H. Hyperhomocysteinemia, DNA methylation and vascular disease. Clin. Chem. Lab. Med., 2007, 45, 1660-1666. (Pubitemid 350232976)
68. Castro, R.; Rivera, I.; Struys, E.A.; Jansen, E.E.; Ravasco, P.; Camilo, M.E.; Blom, H.J.; Jakobs, C.; Tavares de Almeida, I. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin. Chem., 2003, 49, 1292-1296. (Pubitemid 36900615)
69. Yi, P.; Melnyk, S.; Pogribna, M.; Pogribny, I.P.; Hine, R.J.; James, S.J. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem., 2000, 275, 29318-29323. (Pubitemid 32043802)
70. Ingrosso, D.; Cimmino, A.; Perna, A.F.; Masella, L.; De Santo, N.G.; De Bonis, M.L.; Vacca, M.; D'Esposito, M.; D'Urso, M.; Galletti, P.; Zappia, V. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet., 2003, 361, 1693-1699. (Pubitemid 36577442)
71. Stenvinkel, P.; Karimi, M.; Johansson, S.; Axelsson, J.; Suliman, M.; Lindholm, B.; Heimbürger, O.; Barany, P.; Alvestrand, A.; Nordfors, L.; Qureshi, A.R.; Ekström T.J.; Schalling, M. Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J. Intern. Med., 2007, 261, 488-499. (Pubitemid 46587721)
72. Nanayakkara, P.W.; Kiefte-de Jong, J.C.; Stehouwer, C.D.; van Ittersum, F.J.; Olthof, M.R.; Kok, R.M.; Blom, H.J.; van Guldener, C.; ter Wee, P.M.; Smulders, Y.M. Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease. Nephrol. Dial. Transplant., 2008, 23, 2586-2592.
73. Falk, R.J.; Terrell, R.S.; Charles, L.A.; Jennette, J.C. Antineutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc. Natl. Acad. Sci. U.S.A., 1990, 87(11), 4115-4119. (Pubitemid 20217992)
74. Yang, J.J.; Pendergraft, W.F.; Alcorta, D.A.; Nachman, P.H.; Hogan, S.L.; Thomas, R.P.; Sullivan, P.; Jennette, J.C.; Falk, R.J.; Preston, G.A. Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibodyassociated glomerulonephritis. J. Am. Soc. Nephrol., 2004, 15(8), 2103-2114. (Pubitemid 39031349)
75. Ciavatta, D.J.; Yang, J.J.; Preston, G.A.; Badhwar, A.K.; Xiao, H.; Hewins, P.; Nester, C.M.; Pendergraft, W.F.; Magnuson, T.R.; Jennette, J.C.; Falk, R.J. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J. Clin. Invest., 2010, 120(9), 3209-3219.
76. Herrero-Fresneda, I.; Torras, J.; Cruzado, J.M.; Condom, E.; Vidal, A.; Riera, M.; Lloberas, N.; Alsina, J.; Grinyo, J.M. Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy? Am. J. Pathol., 2003, 162, 127-137. (Pubitemid 36041995)
77. Roodnat, J.I.; Mulder, P.G.; Van Riemsdijk, I.; Ijzermans, J.N.; van Gelder, T.; Weimar, W. Ischemia times and donor serum creatinine in relation to renal graft failure. Transplantation., 2003, 75, 799-804. (Pubitemid 36373451)
78. Kosieradzki, M.; Kuczynska, J.; Piwowarska, J.; Wegrowicz-Rebandel, I.; Kwiatkowski, A.; Lisik, W.; Michalak, G.; Danielewicz, R.; Paczek, L.; Rowinski, W.A. Prognostic significance of free radicals: mediated injury occurring in the kidney donor. Transplantation., 2003, 75, 1221-1227. (Pubitemid 36513024)
79. Pratt, J.R.; Parker, M.D.; Affleck, L.J.; Corps, C.; Hostert, L.; Michalak, E.; Lodge, J.P. Ischemic epigenetics and the transplanted kidney. Transplant. Proc., 2006, 38, 3344-3346. (Pubitemid 44908494)
80. Parker, M.D.; Chambers, P.A.; Lodge, J.P.; Pratt, J.R. Ischemia-reperfusion injury and its influence on the epigenetic modification of the donor kidney genome. Transplantation., 2008, 86, 1818-1823.